CS logo
small CS logo
RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity

Houston, Texas, United States
Mental health clinic in Houston, Texas
126 Fred J. Heyne Building, Suite 104, University of Houston, Department of Psychology, Houston, TX 77204

About RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity


During the past decade, RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 4 trials as a collaborator, "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 2 trials as a collaborator, "University of Oklahoma" with 2 trials as a collaborator and "Oklahoma State University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity


According to Clinical.Site data, the most researched conditions in "RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity" are "Anxiety" (3 trials), "Anxiety Disorders" (3 trials), "Smoking, Tobacco" (3 trials), "Alcohol Abuse" (2 trials) and "Smoking" (2 trials). Many other conditions were trialed in "RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity" in a lesser frequency.

Clinical Trials Intervention Types at RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity


Most popular intervention types in "RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity" are "Behavioral" (8 trials), "Other" (3 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Alcohol-Anxiety Personalized Feedback Intervention 2.0" (1 trials), "Aliento" (1 trials), "Control Personalized Feedback Intervention" (1 trials), "Dejar de Fumar Asistente (Mobile App)" (1 trials) and "EASE app" (1 trials). Other intervention names were less common.

Clinical Trials Genders at RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity


The vast majority of trials in "RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity" are 10 trials for "All" genders.

Clinical Trials Status at RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity


Currently, there are NaN active trials in "RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".